Figure 1: CRISPR on-target validation methods for crop editing — Sanger sequencing, PCR-CE, ddPCR, and targeted amplicon NGS — each suited to different editing efficiency ranges and experimental goals.

After weeks of designing guide RNAs, transforming explants, and regenerating plantlets, every crop genome editing project arrives at the same gate: did the edit actually land where it was supposed to, and what fraction of cells carry it? The answer determines which lines advance, which get discarded, and whether the data can survive peer review.

Choose a validation method too coarse, and chimeric or low-efficiency edits slip through. Choose one unnecessarily expensive, and a 200-line screen eats the budget. This article walks through the four main on-target validation methods available for crop CRISPR work — Sanger sequencing, PCR-based capillary electrophoresis (PCR-CE / IDAA), droplet digital PCR (ddPCR), and targeted amplicon NGS — with enough quantitative evidence to decide which one fits your editing goal and efficiency range.

What Sanger Sequencing Captures

Sanger sequencing of a PCR product flanking the target site is the default first check in most plant editing labs. It is accessible, well-understood, and the workflow is simple: amplify the target region, submit the cleaned PCR product for sequencing, and inspect the chromatogram.

A clean single trace with no mixed signal downstream of the cut site usually means a homozygous or biallelic edit. When the trace shows overlapping peaks starting at the expected cleavage position — typically 3 bp upstream of the PAM — the sample carries more than one allele, and Sanger alone cannot resolve the individual sequences.

Deconvolution Tools for Mixed Traces

When the chromatogram shows overlapping peaks, deconvolution software separates the mixed signal into individual allele sequences and estimates their frequencies. Four tools are commonly used in plant editing labs:

• ICE (Inference of CRISPR Edits) — a free web-based tool from Synthego; widely used as a first-pass analysis.
• TIDE (Tracking of Indels by DEcomposition) — a classic algorithm that decomposes mixed traces; accessible via a web interface.
• DECODR (Deconvolution of Complex DNA Repair) — handles complex repair outcomes that ICE and TIDE may misclassify.
• DSDecodeMS / SuperDecode — a local, batch-capable suite developed at South China Agricultural University; reads .ab1 files directly and resolves mutation sequences without uploading data to external servers.

Sanger plus deconvolution works well when editing efficiency exceeds roughly 20%. Above that threshold, the tools produce results that correlate reasonably with NGS-based quantification. For routine screening of T0 lines where the goal is to identify clear knockout candidates, this combination is often sufficient — and it remains the lowest-cost option per sample.

The Catch at Low Editing Efficiency

Plant editing frequently produces efficiency below 20%, especially in transient expression systems, in species without optimized transformation protocols, or when the guide RNA has modest on-target activity. In this range, Sanger-based methods hit three specific limitations.

Three Reasons Sanger Falls Short

• Deconvolution tools lose sensitivity below ~5% allele frequency. Gong et al. (2025) benchmarked ICE, TIDE, and DECODR against targeted amplicon NGS across 20 sgRNA targets in Nicotiana benthamiana. All three tools missed low-frequency alleles that were clearly visible in the NGS data.
• Base-calling software can mask real edits. Most capillary sequencers run PeakTrace by default. Its base-calling parameters are optimized for homozygous templates, and it can suppress the mixed-base signals that deconvolution tools need to work with. A sample carrying a genuine 3% indel may produce a trace that reads as wild type.
• PCR bias distorts allele ratios. Short edited amplicons can out-compete longer wild-type products during amplification, inflating the apparent editing frequency — or the reverse. Qin et al. (2025) documented a case in rice where a sample appeared homozygous by Sanger, but cloning of 32 colonies from the same T3 plant revealed one wild-type clone, below the detection floor of direct Sanger.

The practical takeaway: when editing efficiency is low, when chimerism is suspected, or when zygosity data will appear in a manuscript figure, Sanger alone is not enough.

PCR-CE and ddPCR Fill the Gap

Two methods sit between Sanger and full targeted NGS in cost and resolution. Both provide quantitative, publication-grade data without the full bioinformatics overhead of NGS.

PCR-CE / IDAA

PCR-based capillary electrophoresis (also called IDAA — Indel Detection by Amplicon Analysis) uses a fluorescently labeled primer to amplify the target region, then separates the products by size on a capillary instrument. An indel shifts the amplicon size relative to the wild-type reference, and the relative peak areas give the frequency of edited versus unedited alleles.

In the 2025 benchmarking study, PCR-CE produced editing frequency estimates with an R² of 0.80 against targeted NGS — the highest correlation among non-sequencing methods. The per-sample reagent cost is low, and the workflow scales naturally to 96-well plates. It does require access to a fragment analyzer or a sequencing core that offers fragment analysis service.

Droplet Digital PCR

ddPCR partitions the reaction into thousands of nanoliter-scale droplets, then counts edited and unedited target molecules individually by end-point fluorescence. Because each droplet contains zero or one target molecule, the count is absolute — no standard curve, no reliance on amplification efficiency.

ddPCR achieved an R² of 0.77 against targeted NGS in the benchmarking dataset and retained accuracy at allele frequencies below 1%, a range where all Sanger-based methods had already failed. The main limitation is probe design: each target requires a hydrolysis probe specific to the edit or the wild-type sequence at the cut site, making ddPCR less convenient for screening diverse editing outcomes across multiple guides in parallel.

For projects validating 10 to 50 lines — a common scale for T1 screening after T0 selection — either PCR-CE or ddPCR offers the right balance of quantitative accuracy and cost.

Targeted NGS Sets the Benchmark

Targeted amplicon NGS — amplifying the edited region with barcoded primers and sequencing the pooled products on an Illumina platform — is the reference method against which the others are measured.

Why Per-Molecule Resolution Matters

Unlike Sanger, which reads a population average, NGS reads each individual DNA molecule. A 1% allele is just as visible as a 50% allele, provided enough reads are collected. This per-molecule resolution becomes essential in three scenarios:

• Polyploid crops — a single plant can carry three, four, or six allelic states at one locus, and only per-molecule sequencing can disentangle them.
• Complex alleles — large indels, multi-guide deletions, and HDR events produce sequence outcomes that Sanger deconvolution tools were never designed to resolve.
• Low-frequency events — rare editing outcomes (<1%) that matter for regulatory or safety assessment, such as unexpected on-target rearrangements.

From FASTQ to Allele Table

Analysis tools have matured to the point where raw data processing is no longer the bottleneck. CRISPResso2 takes FASTQ files and outputs allele frequency tables, editing efficiency summaries, and frameshift predictions in a single run. The HiDecode module within the SuperDecode suite supports up to 96 × 96 sample multiplexing — enough for large-scale T0 screens. Most service providers now deliver analyzed data rather than raw reads, so the bioinformatics burden on the lab side is minimal.

The main constraints are practical:

• Turnaround: typically one to two weeks from sample shipment to analyzed report at a service provider.
• Cost per sample: higher than Sanger, though batched amplicon panels bring the per-sample cost down considerably.
• Upfront panel design: primers must be designed and validated before the first sample is run.

How the Methods Compare

Figure 2: Side-by-side comparison of the four on-target validation methods across sensitivity, accuracy, cost, throughput, and polyploid suitability.

What the 2025 Benchmarking Data Shows

The most comprehensive head-to-head comparison to date is the 2025 study by Gong et al., which tested eight quantification methods across 20 sgRNA targets in N. benthamiana, using targeted amplicon NGS as the reference standard. The table below synthesizes their findings together with practical considerations for crop editing workflows.

Two older methods still found in some plant labs — T7E1 and PCR-RFLP — were also tested. They showed regression slopes of 0.25 and 0.77 against NGS, respectively, and both systematically overestimated editing efficiency. Their low sensitivity and poor quantitative accuracy make them unsuitable for any validation purpose beyond a rapid yes/no check on pooled T0 tissue.

Choosing by What You Are Measuring

The right method depends less on the crop species and more on the editing outcome you are chasing — and the efficiency you are likely getting. The four scenarios below cover the most common validation situations in crop CRISPR projects.

Routine T0 Screening

You generated a handful of T0 lines with a validated guide and need to confirm editing before potting them up for T1 seed.

Sanger plus one deconvolution tool is the practical choice. Run both forward and reverse sequencing reads — Qin et al. (2025) noted that the same PCR product can give different editing calls depending on sequencing direction. When the Sanger trace is clean and the called indel is unambiguous, you are done. When the trace is messy or the deconvolution call is uncertain, escalate that specific line to PCR-CE or targeted NGS.

Quantitative Line Ranking

You are screening dozens to hundreds of edited lines and need a single number — percentage of edited alleles — to rank them and select the top candidates for advancement.

PCR-CE offers the best balance of throughput, cost, and accuracy at this scale. It runs in multi-well plate format, and the output — a peak area ratio — is immediately interpretable as editing efficiency. For programs that run line-ranking screens repeatedly, establishing PCR-CE as the default quantification step after initial Sanger screening creates a streamlined, cost-predictable pipeline.

Polyploids, Base Edits, and Publication Figures

You are working with wheat, canola, potato, or another polyploid crop. Or you are validating a base edit, an HDR replacement, or any outcome where knowing the exact sequence of each allele matters. Or you are preparing the final validation data for a manuscript.

Targeted NGS is the right call in all three cases. The per-allele resolution and sub-1% detection floor remove ambiguity that Sanger deconvolution cannot resolve, and the allele frequency tables that NGS produces are what reviewers expect to see in a supplemental dataset.

Copy Number and Low-Frequency Edits

You need absolute copy number data — confirming a CNV edit, counting transgene copies, or verifying that a low-frequency allele detected by screening is real.

ddPCR provides absolute quantification without a reference genome or standard curve. Park et al. (2025) used this approach to confirm a three-copy OsGA20ox1 allele in CRISPR-edited Koshihikari rice after Sanger plus TIDE gave ambiguous results — a clean demonstration of ddPCR as a rescue assay when other methods disagree.

A Staged Workflow

Figure 3: A staged validation workflow for crop CRISPR projects, matching validation intensity to the decision at each generation.

For most crop editing projects, a staged approach keeps costs manageable while ensuring that every data point in the final manuscript has the right resolution behind it:

• T0: Sanger screen all regenerated lines. Advance clear knockouts. Flag ambiguous lines.
• T1: PCR-CE or ddPCR on flagged lines and lead candidates. Get quantitative editing frequencies.
• Lead lines: Targeted NGS for the 3–10 lines heading into publication or field trials. Generate allele tables and confirm absence of wild-type reads.

For guidance on interpreting the NGS results once you have them — indel calls, allele frequency, mosaicism, and zygosity — see the companion article on how to read CRISPR NGS results in crops.

Building the Validation Package

A publication-ready validation package does more than report that an edit occurred. It provides enough evidence for a reviewer to verify the genotype independently.

Three Questions Reviewers Will Ask

• Was the edit confirmed by more than one method? A single Sanger trace with a deconvolution call is a starting point, not the whole answer for lead lines.
• Is the zygosity call supported by sufficient data? Allele frequency from NGS, clone counts from colony screening, or peak area ratios from PCR-CE — include the raw number, not just the conclusion.
• Are the results reproducible across independent samples or generations? If a line was validated at T0, include T1 or T2 confirmation data for the final publication package.

Minimum Components

At minimum, the validation package should include:

• A table mapping each edited line to its on-target genotype, the method used, the editing efficiency or allele frequency with a confidence interval or clone count, and the zygosity call.
• Sanger chromatograms or NGS allele plots for lead candidates, with both forward and reverse reads shown in the supplementary materials.
• The name and version of any deconvolution tool used — different releases of the same tool can return different allele calls from the same input trace.

Confirming Homozygosity

When a line is advanced as "homozygous edited," confirm the absence of the wild-type allele by a second, more sensitive method. Qin et al. (2025) screened 32 colonies from a homozygous-appearing T3 rice line and found one wild-type clone — invisible to direct Sanger but caught by cloning. For lead lines heading into field trials or regulatory submission, this level of scrutiny is appropriate. For lines still in early screening, a clean Sanger trace plus a consistent deconvolution call is typically sufficient.

For researchers planning a larger validation project or designing a multiplexed amplicon panel, the article on CRISPR amplicon sequencing panel design for edited crop lines covers primer design, multiplexing strategy, and coverage planning in detail.

Validation Support for Crop Editing

CD Genomics provides sequencing and analysis services covering the full validation workflow described above.

Services by Validation Stage

• Sanger screening — Sanger Sequencing Services support single-reaction and plate-format PCR product sequencing for T0 screening.
• Quantitative validation — CRISPR Validation Sequencing for Agriculture covers on-target genotyping by Sanger or targeted NGS, with analyzed data returned as allele frequency tables and editing efficiency summaries.
• Full-platform support — the broader CRISPR Sequencing for Agriculture platform includes amplicon panel design, screening sequencing, and off-target analysis for projects that need more than on-target confirmation.

If you are unsure which validation approach fits your project — or whether your editing efficiency warrants escalating from Sanger to a quantitative method — the scientific team can review your target sequences and guide RNA design and recommend a staged validation workflow. All services described here are for Research Use Only.

FAQ

Q1: Can I publish CRISPR-edited plant data with only Sanger sequencing validation?
A: It depends on the journal, the editing efficiency, and the claim. For straightforward knockout confirmation in a diploid crop with a clean chromatogram and a clear indel call, Sanger alone is often accepted — especially when both forward and reverse reads are shown. For quantitative claims about editing efficiency, allele frequencies, or polyploid genotypes, most reviewers will expect supporting data from a quantitative method such as PCR-CE, ddPCR, or targeted NGS. When in doubt, include a second method for your lead lines.

Q2: How do I know if my Sanger trace is "clean enough" to skip NGS?
A: A clean trace shows a single, sharp peak at every position, with no mixed bases downstream of the cut site. If overlapping peaks appear at or after the expected cut position, the sample is not clonal and Sanger alone cannot resolve the alleles. In that case, either clone the PCR product and sequence individual colonies, or escalate to PCR-CE or targeted NGS. Also check whether your sequencing provider uses PeakTrace base-calling software — if they do, a sample with genuinely low-frequency edits may produce a falsely clean trace.

Q3: What is the minimum editing efficiency I can detect with each method?
A: Sanger plus deconvolution tools reliably detect edits above roughly 5–20% allele frequency, depending on the tool, the base caller, and the edit type. PCR-CE can detect edits at roughly 1–2%. ddPCR can go below 1%. Targeted NGS can detect alleles below 0.1%, provided sufficient read depth. These numbers are guidelines, not guarantees — PCR bias, sample quality, and the specific indel size all shift the actual detection floor.

Q4: Does polyploidy change which validation method I should use?
A: Yes. In a tetraploid or hexaploid crop, a single plant can carry multiple allelic states at one locus, and the distinction between a heterozygous biallelic edit and a chimeric mix of edits becomes analytically demanding. Sanger plus deconvolution tools are generally not designed for ploidy beyond diploid. Targeted NGS, with its per-molecule resolution, is the recommended approach for polyploid crops.

Q5: What QC metrics should I check before accepting validation results?
A: For Sanger, confirm that both forward and reverse reads are consistent and that the chromatogram background is low. For PCR-CE, check that the wild-type peak is present in the control and that fragment sizes match the expected indel shift. For ddPCR, verify that the positive and negative droplet populations are well-separated. For targeted NGS, confirm that read depth per amplicon meets the minimum specified in your analysis protocol (typically ≥1,000 reads per target) and that the wild-type control shows the expected sequence with no unexpected variants.

Glossary

Allele frequency: The proportion of sequencing reads or DNA molecules carrying a specific edited allele, expressed as a percentage of total reads at that locus.

Biallelic edit: Both copies of a target gene carry an edit, but the edits may differ from one another (e.g., a +1 insertion on one allele and a −3 deletion on the other).

Chimera / mosaic: A plant in which different cells or tissues carry different editing outcomes, typically because editing occurred after the first cell division in the regenerating explant.

Deconvolution: The computational process of separating a mixed Sanger chromatogram into its component allele sequences and estimating their frequencies.

Homozygous edit: Both copies of the target gene carry the same edit — confirmed by sequencing or cloning that detects no wild-type allele.

IDAA (Indel Detection by Amplicon Analysis): A PCR-CE method that resolves edited from unedited alleles by amplicon size shift on a capillary electrophoresis instrument.

PeakTrace: A base-calling software commonly installed on capillary sequencers; its settings can suppress detection of low-frequency mixed bases in chromatograms.

Targeted amplicon NGS (AmpSeq): Amplification of a target region with barcoded primers followed by high-throughput sequencing; considered the reference method for CRISPR editing quantification.

Zygosity: The allelic state at the edited locus — homozygous (same edit on both copies), heterozygous (one edited, one wild-type), biallelic (different edits on each copy), or chimeric (mixed edit states within one plant).

References

1. Gong, Z., Zhang, Y., Xia, D., Yoon, S., Crisp, P. A., & Botella, J. R. "Comprehensive benchmarking of genome editing quantification methods for plant applications." iScience, 2025, 28(6), 112350. DOI: 10.1016/j.isci.2025.112350
2. Park, H., Kuroha, T., Saika, H., Kuroda, M., & Yoshida, H. "CRISPR/Cas9- and Cas3-mediated modification of copy number variation in rice." Frontiers in Genome Editing, 2025, 7, 1652950. DOI: 10.3389/fgeed.2025.1652950
3. Qin, Y., Yun, S. D., Kim, H. L., Choi, J. Y., Lim, M.-H., Oh, S. A., & Park, S. K. "Molecular Characterization of CRISPR-Cas9-Edited Rice Across Generations and Associated Technical Challenges in Nucleotide Editing Tracing." Plant Breeding and Biotechnology, 2025, 13, 207–228. DOI: 10.9787/PBB.2025.13.207
4. Yun, Jae-Young, et al. "Identification of CRISPR-induced mutations in plants: with a focus on the next-generation sequencing assay." Journal of Plant Biology 65.6 (2022): 435-443.
5. Tsakirpaloglou, N., Septiningsih, E. M., & Thomson, M. J. "Guidelines for Performing CRISPR/Cas9 Genome Editing for Gene Validation and Trait Improvement in Crops." Plants, 2023, 12(20), 3564. DOI: 10.3390/plants12203564